HomeHealth TopicsDigestive SystemSteatotic Liver Disease
Back to Digestive System
Steatotic Liver Disease
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Digestive System

Steatotic Liver Disease

Steatotic liver disease occurs when excess fat builds up in the liver, potentially leading to inflammation, scarring, and long-term health complications.

What is steatotic liver disease?

Your liver is the largest organ inside your body. It helps you digest food, store energy, and remove harmful substances (toxins). Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. It's typical to have some fat in your liver cells, but too much can be a problem.

There are two main types of steatotic liver disease:

  • Metabolic dysfunction-associated steatotic liver disease (MASLD)
  • Alcohol-associated liver disease (ALD)

What is metabolic dysfunction-associated steatotic liver disease (MASLD)?

MASLD is a type of steatotic liver disease that is not caused by heavy alcohol use. It used to be called nonalcoholic fatty liver disease. There are two main forms:

  • Simple fatty liver: In this form, you have fat in your liver but little or no inflammation or liver damage. This form usually does not get bad enough to cause liver damage or complications.
  • Metabolic dysfunction-associated steatohepatitis (MASH): Previously called nonalcoholic steatohepatitis or NASH, this is when MASLD gets worse. In addition to fat in your liver, MASH may cause inflammation and liver damage. This can lead to fibrosis, or scarring, of the liver, which sometimes leads to cirrhosis or liver cancer.

What is alcohol-associated liver disease (ALD)?

ALD is caused by heavy alcohol use. It used to be called alcoholic fatty liver disease or alcoholic steatohepatitis.

Your liver breaks down most of the alcohol you drink so it can be removed from your body. However, the process of breaking it down can create harmful substances that damage liver cells, cause inflammation, and weaken your body's natural defenses. The more alcohol you drink, the more you damage your liver. ALD is the earliest stage of alcohol-related liver disease, followed by alcoholic hepatitis and cirrhosis.

Who is more likely to develop steatotic liver disease?

The cause of MASLD is unknown, but it is more common in people who:

  • Have type 2 diabetes and prediabetes
  • Have obesity
  • Are middle aged or older (although children can also get it)
  • Have high cholesterol or triglycerides
  • Have high blood pressure
  • Take certain medicines, such as corticosteroids and some cancer medicines
  • Have certain metabolic disorders, including metabolic syndrome
  • Have rapid weight loss
  • Have certain infections, such as hepatitis C
  • Have been exposed to certain harmful substances

MASLD is the most common chronic (long-term) liver disease due to increasing rates of obesity, type 2 diabetes, and high cholesterol.

ALD only happens in people who are heavy drinkers, especially those who have been drinking for a long period of time. The risk is higher for women, people with obesity, or those with certain gene changes (known as variants or mutations).

What are the symptoms of steatotic liver disease?

Both MASLD and ALD usually have few or no symptoms. If you do have symptoms, you may feel tired or have discomfort in the upper right side of your abdomen (belly).

How is steatotic liver disease diagnosed?

Because there are often no symptoms, it's not easy to find steatotic liver disease. Your health care provider may suspect you have it if you have abnormal results on liver tests. To make a diagnosis, your provider may use:

  • Your medical history: This may include asking about your alcohol use and any medicines you take.
  • A physical exam: This may include checking your height and weight, as well as checking for signs of liver disease such as an enlarged liver or jaundice, a condition that causes your skin and whites of your eyes to turn yellow.
  • Blood tests: These may include liver function tests and blood count tests.
  • Imaging tests: These tests may be used to check for fat in the liver and for fibrosis.
  • A biopsy: In some cases, a biopsy may be done to confirm the diagnosis and check for liver damage.

What are the treatments for steatotic liver disease?

The first step in treating MASLD is usually weight loss. Losing weight can reduce fat in the liver, inflammation, and fibrosis. If your provider thinks that a certain medicine is the cause of your MASLD, they may tell you to stop or switch medicines. Do not stop taking any medicines unless your provider tells you to. Currently, no medicines are approved for the treatment of MASLD.

The most important part of treating ALD is to stop drinking alcohol. If you need help, you may benefit from counseling, a recovery program, or medicines that reduce cravings or make you feel sick if you drink alcohol.

Both ALD and one type of MASLD can lead to cirrhosis. Health problems caused by cirrhosis may be treated with medicines, surgery, and other medical procedures. If cirrhosis leads to liver failure, you may need a liver transplant.

What are some lifestyle changes that can help?

If you have any type of steatotic liver disease, there are some lifestyle changes that can help:

  • Eat a healthy diet, limiting salt and sugar, while eating plenty of fruits, vegetables, and whole grains.
  • Talk with your provider about vaccinations. If you have chronic liver disease, you are more likely to get infections. Your provider may recommend vaccinations for hepatitis A and B, the flu, and pneumococcal disease.
  • Get regular exercise, which can help you lose weight and reduce fat in the liver.

Check with your provider before using dietary supplements, such as vitamins, or any complementary or alternative medicines. Some supplements or herbal remedies can damage the liver.

Frequently Asked Questions

Yes, early-stage steatotic liver disease and metabolic dysfunction-associated steatohepatitis (MASH) can often be reversed. Clinical trials show that losing 5% to 7% of total body weight substantially reduces hepatic fat accumulation, while a sustained 10% weight loss frequently resolves active liver inflammation and can even regress mild-to-moderate fibrosis.
Yes. Blood levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) frequently remain within normal reference ranges even in patients with advancing MASH or significant fibrosis. To detect silent progression, clinicians use noninvasive risk calculators like the FIB-4 index alongside transient elastography (FibroScan) or magnetic resonance elastography.
Limit acetaminophen intake to less than 2,000 milligrams in a 24-hour period under clinician advice, and strictly avoid alcohol consumption. In addition, use caution with unregulated dietary supplements, especially multi-ingredient fat burners, high-dose vitamin A, kava, and concentrated green tea extract, all of which carry risks of supplement-induced liver injury.
The Mediterranean dietary pattern is the primary therapeutic dietary strategy for steatotic liver disease. It emphasizes polyphenol-rich vegetables, legumes, whole grains, nuts, extra virgin olive oil, and omega-3 fatty acids from fish, while strictly eliminating beverages sweetened with high-fructose corn syrup, refined carbohydrates, and excess saturated fats.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab